Extrahepatic transplantation of islets of Langerhans could aid in better survival of islets after transplantation. When islets are transfused into the liver 60-70% of them are lost immediately after transplantation. An important factor for a successful extrahepatic transplantation is a well-vascularized tissue surrounding the implant. There are many strategies known for enhancing vessel formation such as adding cells with endothelial potential, the combination with angiogenic factors and / or applying surface topography at the exposed surface of the device. Previously we developed porous, micropatterned membranes which can be applied as a lid for an islet encapsulation device and we showed that the surface topography induces human umbilical vein endothelial cell (HUVEC) alignment and interconnection. This was achieved without the addition of hydrogels, often used in angiogenesis assays. In this work, we went one step further towards clinical implementation of the device by combining this micropatterned lid with Mesenchymal Stem Cells (MSCs) to facilitate prevascularization in vivo. As for HUVECs, the micropatterned membranes induced MSC alignment and organization in vitro, an important contributor to vessel formation, whereas in vivo (subcutaneous rat model) they contributed to improved implant prevascularization. In fact, the combination of MSCs seeded on the micropatterned membrane induced the highest vessel formation score in 80% of the sections.
In vitro research in the field of type I diabetes is frequently limited by the availability of a functional model for islets of Langerhans. This method shows that by the addition of theophylline to the glucose buffers, mouse insulinoma MIN6 and rat insulinoma INS1E pseudo-islets can serve as a model for islets of Langerhans for in vitro research. The effect of theophylline is dose- and cell line-dependent, resulting in a minimal stimulation index of five followed by a rapid return to baseline insulin secretion by reducing glucose concentrations after a first high glucose stimulation. This protocol solves issues concerning in vitro research for type I diabetes as donors and the availability of primary islets of Langerhans are limited. To avoid the limitations of using human donor material, cell lines represent a valid alternative. Many different β cell lines have been reported, but the lack of reproducible responsiveness to glucose stimulation remains a challenge.
This work describes a route towards an immune protective device for islet of Langerhans transplantation. We developed a protocol to use MIN6 β cells aggregates as pseudo-islets to overcome the donor shortage issue (chapter 3). In this thesis we explored two different immune protective strategies; a multibore hollow fiber and flat microwell membranes. In chapter 4 we investigated the possibility to use a commercial multibore hollow fiber. In this chapter we showed that we were capable to physically separate islets using agarose macrospheres. Photoacoustic imaging in chapter 5 confirmed these findings. The flat membrane microwell device was developed based on work of Buitinga et al. (1) who developed a poly(ethylene glycol terephthalate)-poly(butylene terephthalate) (PEOT/PBT) microwell scaffold, made by micro thermoforming of dense thin films. We developed a microwell device that consisted of a thin PES/PVP membrane for islet encapsulation and a 0.45μm pore sized PES lid (chapter 6). These membranes were sealed prior to seeding by a custom made seal device. Encapsulated human islets were still responsive to glucose stimulation after 7 days of culture. As a lack of proper vascularization after transplantation and thereby hypoxia is a major contributor to islet death, we studied solutions to overcome this issue. In chapter 7 we showed that micropatterned membranes in combination with MSCs could be used to enhance vascularization in vivo. Finally, we combined the oxygen generating materials of Pedraza et al. (2) with the microwell membrane device of chapter 6 in chapter 8. We showed, similar to Pedraza et al. that the oxygen generating disk had a positive effect on islet viability and function. In this thesis we took the first steps towards an immune protective device, although successful in many aspects additional work is needed to further optimize the devices developed in this work. Therefore in chapter 9 an outlook is presented of different options in order to reach a functional immune protective device for islet encapsulation